The Amyloidosis Channel on VJHemOnc is an independent medical education platform, supported with funding from Prothena (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ISA 2022 | Targeting ER stress to preserve cardiac function in patients with AL amyloidosis
Panagiota-Efstathia Nikolaou, PhD, National and Kapodistrian University of Athens, Athens, Greece, comments on the need to develop better therapies in patients with AL amyloidosis with cardiac involvement, highlighting the potential of targeting endoplasmic reticulum (ER) to alleviate cardiac damage in those patients. This interview took place at the 2022 International Symposium on Amyloidosis (ISA) held in Heidelberg, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
